RealCommentary from
Wyeth May Leave MedImmune Holding the FluMist Bag
Friday March 26, 9:09 am ET

By Adam Feuerstein, Senior Writer

Wyeth (NYSE:WYE - News) said Thursday that it will close a manufacturing
plant that was making the next-generation version of the troubled nasal flu
vaccine FluMist. The decision to shutter the plant once again raises
questions about whether the drugmaker intends to split from its FluMist
partner MedImmune (NasdaqNM:MEDI - News).

All operations at the Marietta, Pa.-based factory will be shuttered by
December, Wyeth said on Thursday. In its news release, Wyeth said the plant
was making an "investigational influenza vaccine," which company spokesman
Doug Petkus confirmed is the experimental, refrigerated version of FluMist.

Adam Feuerstein writes regularly for In keeping with TSC's
editorial policy, he doesn't own or short individual stocks, although he
owns stock in He also doesn't invest in hedge funds or other
private investment partnerships. He invites you to send your feedback.